期刊文献+

伊贝沙坦、缬沙坦和氯沙坦对高血压左室肥厚的影响 被引量:3

Effectiveness of Irbesartan,Valsartan,Losartan on Left Ventricular Hypertrophy Caused by Hypertension
下载PDF
导出
摘要 目的:比较伊贝沙坦、缬沙坦和氯沙坦对高血压左室肥厚的疗效。方法:选择130例高血压患者,随机分为3组,分别给予伊贝沙坦、缬沙坦和氯沙坦治疗6个月。观察治疗前后舒张末期室间隔厚度(IV ST)、舒张末期左室后壁厚度(PW T)、左室重量(LVM)、左室重量指数(LVM I)的变化及24 h平均血压的变化。结果:三组治疗前后血压明显下降(P<0.01),IV ST、PW T、LVM和LVM I明显下降(P<0.01),三组间比较差异无显著性(P>0.05)。结论:伊贝沙坦、缬沙坦和氯沙坦均可有效的降低血压,并明显改善心室肥厚。 Objective:To compare the effectiveness of Irbesartan, Valsartan,Losartan on left ventricular hypertrophy caused by hypertension. Method: 130 patients with hypertension were randomly divided into 3 groups and each group was administrated Irbesartan,Valsartan,Losartan respectively for 6 months. Interventricular septum thickness (IVST) at the end of dialation, posterior wall thickness (PWT) at the end of dialation, left ventricular weight (LVW), left ventricular weight index(LVWI),mean blood pressure of 24 hours were investigated before and after administration. Result:There were significantly decreased blood pressure,IVST,PWT, LVW, LVWI (P〈0.01) after the treatment. Statistical differeace among the three groups were not observed. Conclusion :Irbesartan,Valsartan,Losartan are all effective on lowing blood pressure and reversing left ventricular hypertrophy.
出处 《中国误诊学杂志》 CAS 2007年第1期3-5,共3页 Chinese Journal of Misdiagnostics
关键词 高血压/并发症 高血压/药物疗法 肥大 左心室 联苯化合物/治疗应用 四唑类/治疗应用 缬氨酸/类似物和衍生物 洛沙坦/治疗应用 Hypertension/complications Hypertension/drug therapy Hypertrophy,left ventricular Biphenyl compounds/therapeutic use ~ Tetrazoles/therapeutie use Valine/analogs&derivatives Losartan/therapeuticuse
  • 相关文献

参考文献4

  • 1Verdecchia P,Angeli F,Borgioni C,et al.Changes in cardiovascular risk by reduction of left ventricular mass in hypertension:a meta-analysis[J].Am J Hypertens,2003,16 (11 Pt 1):895-899.
  • 2Diamond JA,Phillips RA.Antihypertensive drugs and the heart[J].Minerva Med,2005,96(4):247-260.
  • 3Dahlof B,Devereux RB,Kjeldsen SE,et al.LIFE Study Group.Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):a randomised trial against atenolol[J].Lancet,2002,359 (9311):995-1003.
  • 4Dahlof B.Left ventricular hypertrophy and angiotensin Ⅱ antagonists[J].Am J Hypertens,2001,14 (2):174-182.

同被引文献24

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部